/
INVA
$20.75-$0.06 (-0.29%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.5B
72M shares
52-week range
$16.52 – $25.15
49% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change+$4.41
Innoviva, Inc. Common Stock
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
www.inva.com- Employees
- 159
- IPO / List date
- Oct 5, 2004
- HQ
- BURLINGAME, CA
Held by traders on TradeandTell
No one on the platform currently holds INVA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 4,055,632 | $94.5M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2013-06-17 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded INVA yet.
